Superantigenic exotoxin production by isolates of Staphylococcus aureus from the Kawasaki syndrome patients and age-matched control children

References

1. Ohkuni H., Todome Y., Igarashi H. Possible etiological role in Kawasaki disease of viridans group streptococci producing erythrogenic toxin: report on the project study of the Research Committee on Kawasaki Disease, Japan Heart Foundation. In Takahashi M., Taubert K. (eds) Proceedings of the Fourth International Symposium on Kawasaki Disease Dallas: American Heart Association; 199360–76
   [Google Scholar]
2. Ohkuni H., Todome Y., Mizuse M. Biologically active extracellular products of oral viridans streptococci and the aetiology of Kawasaki disease. J Med Microbiol 1993; 39:352–362
   [Google Scholar]
3. Takada H., Kawabata Y., Tamura M. Cytokine induction by extracellular products of oral viridans group streptococci. Infect Immun 1993; 61:5252–5260
   [Google Scholar]
4. Leung Y. M., Meissner H. C., Fulton D. R., Murray D. L., Kotzin B. L., Schlievert P. M. Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome. Lancet 1993; 342:1385–1388
   [Google Scholar]
5. Muller H. E. ABTS peroxidase medium as a highly sensitive plate assay for detection of hydrogen peroxidase production in bacteria. J Microbiol Methods 1984; 2:101–102
   [Google Scholar]
6. Harada K., Katsukawa R., Kotani S. Bacteriological study on the etiology of Kawasaki disease (MCLS)—search for non-β haemolytic bacteria capable of producing exotoxins similar to streptococcal pyrogenic exotoxin. Pediatr Jpn 1986; 27:921–928 (in Japanese)
   [Google Scholar]
7. Ushioda H., Terayama T., Sakai S., Zen-Yoji H., Nishiwaki M., Hidano A. Coagulase typing of Staphylococcus aureus and its application in routine work. In Jeljaszewicz J. (ed) Staphylococci and staphylococcal infection Stuttgart: Gustav Fischer; 198177–83
   [Google Scholar]
8. Van de Rijn I., Kessler R. E. Growth characteristics of group A streptococci in a new ch emically defined medium. Infect Immun 1980; 27:444–448
   [Google Scholar]
9. Igarashi H., Fujikawa H., Shingaki M., Bergdoll M. S. Latex agglutination test for staphylococcal toxic shock syndrome toxin 1. J Clin Microbiol 1986; 23:509–512
   [Google Scholar]
10. Fujikawa H., Igarashi H. Rapid latex agglutination test for detection of staphylococcal exotoxins A to E that uses high-density latex particles. Appl Environ Microbiol 1988; 54:2345–2348
    [Google Scholar]
11. Kondo I., Sakurai S., Sarai Y. Purification of exfoliatin produced by Staphylococcus aureus of bacteriophage group 2 and its physicochemical properties. Infect Immun 1973; 8:156–164
    [Google Scholar]
12. Abe J., Kotzin B. L., Meissner C. Characterization of T cell repertoire changes in acute Kawasaki disease. J Exp Med 1993; 177:791–796
    [Google Scholar]
13. Curtis N., Chan B., Levin M. Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome. Lancet 1994; 343:299
    [Google Scholar]
14. Nishiyori A., Sakaguchi M., Kato H., Igarashi H., Miwa K. Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome. Lancet 1994; 343:299–300
    [Google Scholar]
15. Abe J., Takeda T., Kosaka T., Kobayashi N. Specificity of T cell stimulated by superantigen producing bacteria isolated from patients with Kawasaki disease. Abstract of the 13th National Conference of Kawasaki Disease 1993; 43: (in Japanese)
    [Google Scholar]
16. Takeda T., Abe J., Kosaka T., Kobayashi N. Characterization of S. aureus strains isolated from the throat of patients with Kawasaki disease. Abstract of the 13th National Conference of Kawasaki Disease 1993; 45: (in Japanese)
    [Google Scholar]